Related references
Note: Only part of the references are listed.Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Joerg Vollmer et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Generation of Human Dendritic Cells That Simultaneously Secrete IL-12 and Have Migratory Capacity by Adenoviral Gene Transfer of hCD40L in Combination With IFN-γ
Ilka Knippertz et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Dendritic cell vaccination and immune monitoring
E. H. J. G. Aarntzen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
A phase 1 clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells.: Analysis of toxicity and immune response to the vaccine and of IL-10-1082 promoter genotype as predictor of disease progression
Erika M. von Euw et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Current approaches in dendritic cell generation and future implications for cancer immunotherapy
Sandra Tuyaerts et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
DC-based cancer vaccines
Eli Gilboa
JOURNAL OF CLINICAL INVESTIGATION (2007)
New developments in dendritic cell-based vaccinations:: RNA translated into clinics
F Grünebach et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
CpG oligodeoxynucleotides inhibit tumor growth and reverse the immunosuppression caused by the therapy with 5-fluorouracil in murine hepatoma
Xian-Song Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: Comparison with immunodominant peptide-pulsed DCs
M Nakamura et al.
ONCOLOGY (2005)
Clinical applications of dendritic cell vaccination in the treatment of cancer
DC Lee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Induction of potent antitumor immunity by in situ targeting of intraturnoral DCs
K Furumoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
CpG-DNA as immune response modifier
AH Dalpke et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2004)
A novel testicular RhoGAP-domain protein induces apoptosis
MH Modarressi et al.
BIOLOGY OF REPRODUCTION (2004)
MIP-3α transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity
B Bonnotte et al.
JOURNAL OF IMMUNOLOGY (2004)
Intratumor CpG-oligodeoxynucleotide injection induces protective antitumor T cell immunity
AS Lonsdorf et al.
JOURNAL OF IMMUNOLOGY (2003)
Intra-tumoral injection of CpG results in the inhibition of tumor growth in murine Colon-26 and B-16 tumors
S Sharma et al.
BIOTECHNOLOGY LETTERS (2003)
Tumor suppression induced by intratumor administration of adenovirus vector expressing NK4, a 4-kringle antagonist of hepatocyte growth factor, and naive dendritic cells
T Kikuchi et al.
BLOOD (2002)
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody
AP Vicari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity
T Kikuchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells
M Bauer et al.
JOURNAL OF IMMUNOLOGY (2001)
Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma
R Lau et al.
JOURNAL OF IMMUNOTHERAPY (2001)
Dendritic cell biology and regulation of dendritic cell trafficking by chemokines
C Caux et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2000)
Macrophage inflammatory protein 3α transgene attracts dendritic cells to established murine tumors and suppresses tumor growth
T Fushimi et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)